Propranolol — the "stage fright pill"

Propranolol is a beta blocker, originally developed for heart conditions. It works by blocking the effects of adrenaline on your body — specifically, the beta-adrenergic receptors that drive your racing heart, trembling hands, shaky voice, and sweaty palms. It has been used off-label for performance anxiety since the 1970s and is probably the medication most people think of when they hear "pill for public speaking."

The typical dose is 10–40mg taken 30 to 60 minutes before the event. It does not cross the blood-brain barrier significantly enough to act as a sedative, so you do not feel drugged or foggy. What happens is more targeted: your body stops doing the things that make you feel panicked, which in turn makes the panic feel less intense. Musicians, surgeons, and public speakers have used it for decades.

What the research says

Propranolol clearly reduces visible anxiety during speech — one early study by James et al. (1983) found that trained observers rated speakers as significantly less anxious on propranolol versus placebo, and speakers themselves reported lower anxiety. However, the same study also found that propranolol impaired recall of difficult words in anxious subjects, suggesting a cognitive trade-off.

A 2016 systematic review by Steenen et al., looking at randomised controlled trials of propranolol for anxiety disorders, concluded that the evidence base is insufficient to support its routine use. They found the quality and quantity of studies to be limited, with most being small and decades old. Their conclusion: propranolol appears most useful for performance-specific anxiety where the dominant symptoms are physical, but there is not enough robust evidence to recommend it broadly.

More recently, a 2022 review by Szeleszczuk and Frączkowski confirmed that propranolol is most effective for short-term, situational use — reducing physical symptoms before a specific event — rather than as a treatment for anxiety itself.

The honest picture: propranolol works well for the body. It quiets the tremor, slows the heart, steadies the voice. But it does not touch the thoughts. If your anxiety is primarily cognitive — the catastrophic predictions, the certainty you will humiliate yourself, the replaying of past failures — propranolol will calm your hands while your mind continues to spiral. And there is a subtler problem: if you always take propranolol before speaking, you never learn that you can handle the anxiety without it. You attribute every successful presentation to the pill, not to yourself. This can actually reinforce the avoidance pattern rather than break it.

SSRIs — the long-term option

SSRIs (selective serotonin reuptake inhibitors) like sertraline, paroxetine, and escitalopram are the first-line medication for social anxiety disorder, which is the clinical condition that includes severe public speaking anxiety. Unlike propranolol, SSRIs are taken daily and work over weeks, gradually altering serotonin levels in the brain to reduce overall anxiety.

These are serious medications with a genuine evidence base. A meta-analysis by Blanco et al. (2003) found that SSRIs produced a mean effect size of 0.65 for social anxiety disorder — a moderate-to-large effect — and were consistently superior to placebo across multiple trials. Hedges et al. (2007) confirmed this across 15 randomised controlled trials, finding all studied SSRIs significantly more effective than placebo. The number of patients who responded to medication was roughly double the number who responded to placebo.

SSRIs at a glance

How they work: Increase serotonin availability in the brain. Reduce general anxiety levels over 2–6 weeks.

Typical use: Daily, for months. Not a "take before the event" medication.

Evidence: Strong for social anxiety disorder. SSRIs are the most well-supported medication class for this condition (Blanco et al., 2003; Hedges et al., 2007).

Side effects: Can include nausea, insomnia or drowsiness, sexual dysfunction, weight changes, and withdrawal symptoms when stopping. Side effects vary between individuals and between specific SSRIs.

SSRIs are appropriate when speaking anxiety is part of a broader pattern of social anxiety that affects daily life. If you avoid not just presentations but also meetings, phone calls, social events, and casual conversations because of anxiety, an SSRI may be the right intervention. But they are not a light-touch solution. They take weeks to work, they change your brain chemistry on a daily basis, and they come with side effects that some people find significant. For someone whose only anxiety trigger is public speaking, SSRIs are typically more treatment than the problem requires.

Benzodiazepines — the one to be cautious about

Benzodiazepines (lorazepam, diazepam, alprazolam) are fast-acting anti-anxiety medications that work by enhancing the effect of GABA, a neurotransmitter that slows brain activity. They reduce anxiety quickly and effectively — often within 30 minutes. That speed makes them appealing for situational use.

But benzodiazepines carry serious downsides that make them a poor choice for public speaking anxiety. They cause sedation, which dulls your thinking and delivery. They impair memory formation, which means you may give the presentation and barely remember it. They carry a real risk of dependence with repeated use — your body adapts to the drug, and you need more to get the same effect. And like propranolol, they prevent you from learning that you can handle the situation without chemical support.

Most clinical guidelines now recommend against benzodiazepines for social anxiety except as a short-term bridge while waiting for an SSRI to take effect. For speaking anxiety specifically, they create a paradox: they make you feel less anxious, but they also make you a worse speaker. The trade-off is rarely worth it.

What no medication does

Here is the part that gets left out of most conversations about public speaking anxiety medication. Every medication on this page addresses symptoms. None of them addresses the cause.

The cause of public speaking anxiety is a learned fear response — your brain has associated speaking with danger, and your body responds accordingly. That association was built over years through negative experiences, avoidance patterns, and catastrophic thinking. The only way to undo it is through repeated, graduated exposure to the feared situation in conditions that teach your brain the danger is not real. This is the mechanism behind exposure therapy, and it is the most well-supported treatment for phobic anxiety (Carpenter et al., 2018).

Medication can make that exposure process more tolerable. A well-timed dose of propranolol before an early exposure session can prevent the physical symptoms from overwhelming you, giving you a chance to actually engage with the experience. An SSRI can lower your overall arousal enough that exposure tasks feel challenging rather than impossible. Used strategically, medication is a useful support tool.

Used as a replacement for exposure, medication becomes another form of avoidance. You manage the symptom event by event but never build the underlying capacity to tolerate and recover from anxiety on your own. The moment you stop the medication, the fear is exactly where you left it.

Build the capacity, not the dependency

Nervless is a structured exposure programme for public speaking anxiety — 53 sessions that progressively train your nervous system to handle speaking, with AI feedback on your delivery. The kind of practice that makes medication optional, not essential.

Start free at nervless.app

The smart way to use medication

Medication is not bad. It is not cheating. It is a legitimate tool with legitimate uses. The problem is when it becomes the only tool.

If your speaking anxiety is primarily physical — the shaking, the racing heart, the trembling voice — and you have a high-stakes event coming up, propranolol is a reasonable short-term strategy. Take it before the event, deliver the presentation with a calmer body, and use that positive experience as evidence that you can speak successfully. But do not stop there. Start building the exposure practice that will eventually make the propranolol unnecessary.

If your anxiety is broader and more pervasive — affecting social situations beyond speaking, causing significant daily impairment — talk to a doctor about SSRIs. They work, the evidence is strong, and they can lower the baseline enough to make therapy and structured practice more accessible.

If someone suggests a benzodiazepine for speaking anxiety, proceed with real caution. The risks usually outweigh the benefits for this specific use case.

And in all cases, treat medication as the scaffolding, not the building. The building is the practice, the exposure, and the gradual rewiring of a nervous system that learned the wrong lesson about speaking. That work cannot come from a pill. It can only come from doing the thing, again and again, until your body learns what your mind already knows: this is not dangerous. You can handle it.

If your anxiety is severe or you are unsure which approach is right for you, consult a medical professional. This article is informational — it is not a substitute for medical advice.

References

Blanco, C., Schneier, F.R., Schmidt, A., Blanco-Jerez, C.R., Marshall, R.D., Sánchez-Lacay, A., & Liebowitz, M.R. (2003). Pharmacological treatment of social anxiety disorder: A meta-analysis. Depression and Anxiety, 18(1), 29–40. doi.org/10.1002/da.10128

Carpenter, J.K., Andrews, L.A., Witcraft, S.M., Powers, M.B., Smits, J.A.J., & Hofmann, S.G. (2018). Cognitive behavioural therapy for anxiety and related disorders: A meta-analysis of randomised placebo-controlled trials. Depression and Anxiety, 35(6), 502–514. doi.org/10.1002/da.22728

Hedges, D.W., Brown, B.L., Shwalb, D.A., Godfrey, K., & Larcher, A.M. (2007). The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: A meta-analysis of double-blind, placebo-controlled trials. Journal of Psychopharmacology, 21(1), 102–111. doi.org/10.1177/0269881106065102

James, I.M., Burgoyne, W., & Savage, I.T. (1983). Effect of pindolol on stress-related disturbances of musical performance: preliminary communication. Journal of the Royal Society of Medicine, 76(3), 194–196. Also: James et al. (1977). The effect of beta adrenergic blocking drugs on speakers' performance and memory. PubMed

Steenen, S.A., van Wijk, A.J., van der Heijden, G.J.M.G., van Westrhenen, R., de Lange, J., & de Jongh, A. (2016). Propranolol for the treatment of anxiety disorders: Systematic review and meta-analysis. Journal of Psychopharmacology, 30(2), 128–139. doi.org/10.1177/0269881115612236

Szeleszczuk, Ł., & Frączkowski, D. (2022). Propranolol versus other selected drugs in the treatment of various types of anxiety or stress, with particular reference to stage fright and PTSD. International Journal of Molecular Sciences, 23(17), 10099. doi.org/10.3390/ijms231710099